OSI-930 is a small-molecule tyrosine kinase inhibitor selective for c-Kit, KDR (VEGFR2), and CSF-1R (c-Fms), provided as a solid for research use. It exhibits in vitro potency with reported IC50s of ~80 nM (Kit), 9 nM (KDR), and 15 nM (CSF-1R) and has shown antitumor activity in preclinical models.
- Selective inhibition of c-Kit, KDR, and CSF-1R.
- Low nanomolar potency against VEGFR2 (KDR).
- Useful for kinase inhibition and cancer biology research.
- High listed purity (≈98.3%).
- Supplied as a solid in small-scale quantities suitable for laboratory studies.